Cinclus Pharma: Initiating pivotal phase III study
29 augusti, 12:00
29 augusti, 12:00
Redeye leaves a comment following Cinclus’ announcement earlier today of having initiated its phase III HEEALING 1 study in severe erosive GERD. We view this as a pivotal milestone that provides clarity on the timeline and pathway to market entry of linaprazan glurate, setting the stage for significant value creation ahead.
29 augusti, 12:00
Redeye leaves a comment following Cinclus’ announcement earlier today of having initiated its phase III HEEALING 1 study in severe erosive GERD. We view this as a pivotal milestone that provides clarity on the timeline and pathway to market entry of linaprazan glurate, setting the stage for significant value creation ahead.
PPM
PPM
1 DAG %
Senast
Saab
Idag, 16:36
Saab ingår samarbetsavtal med polska PGZ
SEB
Idag, 14:51
Analys: Favoriterna bland storbankerna
OMX Stockholm 30
1 DAG %
Senast
2 577,63